sitagliptin glp 1 Dapagliflozin and combination therapy a clear benefit The incretin system: glucagon-like peptide-1

The results can last several months, but maintenance treatments are necessary to sustain the effects

This work was supported by grants from the National Natural Science Foundation of China (32270727, 32000141), the Natural Science Foundation of Fujian Province (2021J01029) and the Fundamental Research Funds for the Central Universities (20720210094) to Y.C., grants from the Research Grants Council of Hong Kong (CRS_CUHK405/23, AoE/M-402/25-N, AoE/M-05/12, CUHK14106823, C4033-19E, C4002-20W, C4002-21EF, C2003-22WF, R4005-18, C4014-23G, G-CUHK409/23 and Senior Research Fellow Scheme SRFS2122-4S01), the Chinese University of Hong Kong (CUHK) Research Committee, and Science Faculty to L.J., as well as grants from the State Key Laboratory of Chemical Biology and Drug Discovery (PolyU), the Research Grants Council (RGC) (Hong Kong) (14105517) and the Hong Kong Polytechnic University (University Grants Committee) (P0046618) to W.C.Y.L

Thyroid Disease Treatment Thyroid disease can cause unexplained weight gain that is difficult to lose

The weakening of cellular antioxidant defenses caused by reduced GSH levels accelerates chondrocyte death and drives the progression of OA pathology